Pulmonary Drug Delivery Market Sales Revenue Clinical Trials Pipeline Report

The demand for new and innovative drug delivery systems has been on a rising trend with the pharmaceutical companies concentrating on developing innovative methods for this area. It is the result of these continued efforts, which have led to the ever rising popularity of pulmonary drug delivery methods across the globe. Pulmonary drug delivery system uses the respiratory tract to deliver drugs into the lungs in order to treat diseases such as asthma, COPD and cystic fibrosis. This market has been attracting significant investments by the pharma companies with relation to development of novel treatment methods.

Download Report:

https://www.kuickresearch.com/report-Pulmonary-Drug-Delivery-Market-&-Clinical-Pipeline-Insight.php

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

"Pulmonary Drug Delivery Market & Clinical Pipeline Insight" Table of Contents

1. Introduction to Pulmonary Drug Delivery

2. Pulmonary Drug Delivery Mechanism
2.1 Segments of Pulmonary Drug Delivery System
2.2 Mechanisms of Drug Delivery

3. Why Need for Pulmonary Drug Delivery?

4. Pulmonary Drug Delivery Market Outlook
4.1 Market Overview
4.2 Clinical Pipeline Analysis

5. Pulmonary Drug Delivery Market Dynamics
5.1 Favorable Market Drivers
5.2 Key Issues to be Discussed

6. Future of Pulmonary Drug Delivery Market

7. Pulmonary Drug Clinical Insight by Phase, Country & Target Indication
7.1 Unknown Phase
7.2 Research
7.3 Preclinical
7.4 Clinical
7.5 Phase I
7.6 Phase I/II
7.7 Phase II
7.8 Phase II/III
7.9 Phase III
7.10 Preregistration
7.11 Registered

8. Marketed Pulmonary Drug Profiles

9. Suspended & Discontinued Pulmonary Drug Profiles
9.1 No Development Reported
9.2 Discontinued
9.3 Market Withdrawal
9.4 Suspended

10. Competitive Landscape
10.1 Allergan Inc. (MAP Pharmaceuticals)
10.2 AstraZeneca (Pearl Therapeutics)
10.3 Bayer HealthCare Pharmaceuticals
10.4 Boehringer Ingelheim
10.5 Gilead Sciences
10.6 Merck & Co
10.7 Teva Pharmaceutical (Microdose Therapeutx)
10.8 Novartis
10.9 Pfizer
10.10 Vectura Group

Figure 1-1: Drug Delivery Methods
Figure 1-2: Evolution Timeline of Pulmonary Drug Delivery Method
Figure 2-1: Segments of Pulmonary Drug Delivery System
Figure 4-1: Global Pulmonary Drug Delivery Market (US$ Billion), 2013-2018
Figure 4-2: Market Segmentation of Pulmonary Drug Delivery
Figure 4-3: Pulmonary Drugs in Clinical Trial by Phase (%), 2014
Figure 4-4: Number of Pulmonary Drugs in Clinical Trial by Phase, 2014
Figure 4-5: No Development Pulmonary Drugs in Clinical Trial by Phase (%), 2014
Figure 4-6: No Development Pulmonary Drugs in Clinical Trial by Phase (%), 2014
Figure 4-7: Discontinued Pulmonary Drugs in Clinical Trial by Phase (%), 2014
Figure 4-8: Discontinued Pulmonary Drugs in Clinical Trial by Phase (%), 2014
Figure 4-9: Suspended Pulmonary Drugs in Clinical Trial by Phase (%), 2014
Figure 4-10: Suspended Pulmonary Drugs in Clinical Trial by Phase (%), 2014

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.